In January of 2019, WHO recommended the rescheduling of cannabis. The U.S. is preparing to address rescheduling of cannabis at the upcoming United Nations Commission on Narcotic Drugs (CND) meeting.
The U.S. Food and Drug Administration Agency has opened up a short comment period intended to bring the public’s voice into their decision process. Lowell J. Schiller, Acting Associate Commissioner for Policy, posted Feb 25, 2019 a request for those interested in submitting comments about the World Health Organization (WHO) recommendations.
Presumably, your comments are meant to inform U.S. policy ahead of the March 18-22 meeting of the United Nations CND in Vienna, Austria. Electronic comments must be submitted on or before March 14, 2019.
If interested in commenting, please visit Regulations.gov.